Pharmamarketeer

Pfizer COVID-19 vaccine to be given to older and at-risk Americans

Pfizer COVID-19 vaccine to be given to older and at-risk Americans

The FDA have approved a booster dose of the Pfizer BioNTech COVID-19 vaccine for those aged 65 and above, as well as for immunocompromised people aged 18 to 64 years. Millions of people who had their second dose of the vaccine at least six months ago will be able to receive their booster shot in the US this week.

Pfizer COVID-19 vaccine to be given to older and at-risk Americans | Pharmafile

Advertentie(s)